Clinical outcomes and risk factor of immune checkpoint inhibitors-related pneumonitis in non-small cell lung cancer patients with chronic obstructive pulmonary disease.

BMC Pulm Med · 2022 · PMC9716670 · PMID 36456932

Europe PMC DOI

hedged sentences

0.0930

closest p · 1.9× alpha

0.0930

boldest claim

The sentences

did not reach statistical significanceP = 0.093so close (0.05 < p ≤ 0.1)

13.0%), but this difference did not reach statistical significance (P = 0.093).

also in 111,027 other papers

an increasing trendP = 0.093so close (0.05 < p ≤ 0.1)

In addition, an increasing trend in the incidence of CIP among patients with pulmonary fibrosis on baseline chest CT scans (27.3% vs. 13.0%, P = 0.093).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.